795TiP A first-in-human phase I study of LY4170156, an antibody-drug conjugate targeting folate receptor α (FRα)-expressing advanced solid tumors. - Ray-Coquard, I.L.; Liu, J.F.; O'Malley, D.; Oaknin, A.; Pothuri, B.; Lorusso, D.; Eskander, R.N.; Westin, S.; Lakhani, N.J.; McKean, W.B.; Koyama, T.; Kitano, S.; et al. (Annals of Oncology, 2024)